Designing nanofibrous poly(ε-caprolactone)/hydroxypropyl cellulose/zinc oxide/Melilotus Officinalis wound dressings using response surface methodology.
Drug release
Electrospun nanofibers
Hydroxypropyl cellulose (HPC)
Melilotus Officinalis (MO) extract
Poly(ε-caprolactone)
Wound dressing
Zinc oxide nanoparticles (ZnO)
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
15 Dec 2022
15 Dec 2022
Historique:
received:
15
08
2022
revised:
17
10
2022
accepted:
21
10
2022
pubmed:
30
10
2022
medline:
3
12
2022
entrez:
29
10
2022
Statut:
ppublish
Résumé
Nanofibrous wound dressing is one of the most prominent stratagems for wound caring/management. This research is an approach for designing an electrospun wound dressing based on poly(ε-caprolactone)/hydroxypropyl cellulose/zinc oxide nanoparticles (PCL/HPC/n-ZnO), in which response surface methodology (RSM) was utilized to ascertain the optimum sample. It was observed that the addition of n-ZnO and Melilotus Officinalis (MO) extract could increase the fibers mean diameter, pore size, and crystallinity of mats. The mentioned quantities for a sample with the highest MO content (PHZM10) were equal to 469±105 nm, 544±370 nm, and 49.67%, respectively. Moreover, enhancing the amount of MO led to an increase in mechanical properties. In this respect, the PHZM10 sample had the modulus, strength, and toughness of 82.41±0.61, 20.45±0.30 MPa, and 4194.86 mJ, respectively. Also, according to the MTT assay, no cytotoxicity was reported from any of the manufactured samples. Besides, it was concluded that the antibacterial activity and nanofibrous structure of mats, and also their potential for release of MO extract could accelerate the wound healing. Hence, the wound closure index for the PHZM10 group was 99.3±1.1%. Based on all noted results, the PCL/HPC/n-ZnO/MO electrospun mats can be proposed as reassuring wound dressing candidates.
Identifiants
pubmed: 36309291
pii: S0378-5173(22)00893-6
doi: 10.1016/j.ijpharm.2022.122338
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
caprolactone
56RE988L1R
hydroxypropylcellulose
9XZ8H6N6OH
Plant Extracts
0
polycaprolactone
24980-41-4
Zinc Oxide
SOI2LOH54Z
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122338Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.